1. Clinical significance of low-density lipoprotein-triglycerides in patients with familial hypercholesterolemia. (August 2022) Authors: Ogura, M.; Ito, Y.; Harada-Shiba, M. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of antisense drug targeting PCSK9. (August 2018) Authors: Harada-Shiba, M.; Wada, F.; Tachibana, K.; Yamamoto, T.; Kobayashi, T. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of pitavastatin in paediatric FH compared with other statins from Cochrane Database. (September 2016) Authors: Harada-Shiba, M.; Ohta, T.; Ohtake, A.; Okada, T.; Arisaka, O.; Kastelein, J.; Luirink, I. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias. (May 2015) Authors: Stefanutti, C.; D'Alessandri, G.; Petta, A.; Harada-Shiba, M.; Julius, U.; Soran, H.; Moriarty, P.M.; Romeo, S.; Drogari, E.; Jaeger, B.R. Journal: Atherosclerosis Issue: Volume 18(2015) Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hesperetin enhances systemic reverse cholesterol transport by increasing ATP-binding cassette transporter A1 (ABCA1) expression in macrophages. (December 2020) Authors: Ota-Kontani, A.; Hirata, H.; Ogura, M.; Uto-Kondo, H.; Kobayashi, N.; Tsuchiya, Y.; Harada-Shiba, M. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High lysophosphatidylcholine and low phosphatidylcholine concentrations in HDL phospholipids are associated with atherosclerosis in relation to decreased cholesterol efflux capacity. (December 2020) Authors: Ogura, M.; Fujita, T.; Katayama, Y.; Harada-Shiba, M. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High-density lipoprotein phospholipid content and apolipoprotein A-I level are determinants of cholesterol efflux capacity in patients with familial hypercholesterolemia. (September 2016) Authors: Ogura, M.; Harada-Shiba, M. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term treatment with evolocumab homozygous familial hypercholesterolemia patients: Results from the trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (Taussig). (September 2016) Authors: Stein, E.A.; Sampietro, T.; Santos, R.; Harada-Shiba, M.; Bruckert, E.; Blom, D.; Hovingh, G.K.; Couture, P.; Blaha, V.; Farnier, M.; Descamps, O.; Soran, H.; Kasichayanula, S.; Gibbs, J.; Kurtz, C.; Tang, L.; Honarpour, N.; Wasserman, S.M.; Raal, F.J. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel Insights From Genetic And Clinical Data Of Familial Hypercholesterolemia In Patients Presenting With Acute Coronary Syndrome: Explore-J Registry. (August 2019) Authors: Harada-Shiba, M.; Arai, H.; Nohara, A.; Sato, K.; Hirayama, A.; Ako, J.; Naito, Y.; Ozaki, A.; Nakamura, M. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Proprotein convertase subtilisin/kexin 9 (PCSK9) V4I variant with LDLR mutations modifies the phenotype of heterozygous familial hypercholesterolemia. (September 2016) Authors: Hori, M.; Ohta, N.; Takahashi, A.; Ogura, M.; Makino, H.; Tamanaha, T.; Miyamoto, Y.; Harada-Shiba, M. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗